Skip to main content

Table 1 Cytokines with osteoclastogenic activities in DM

From: Derangement of calcium metabolism in diabetes mellitus: negative outcome from the synergy between impaired bone turnover and intestinal calcium absorption

Cytokines

Major findings

Refs.

RANKL

Elevated in plasma of T1DM children

[101]

Elevated in bone marrow of polygenic TallyHo/JngJ T2DM mice

[102]

Increased mRNA expression in STZ-treated T1DM mice

[48]

IL-1

Elevated in serum during early onset of T1DM in STZ-treated mice

[103]

IL-6

Elevated in blood and bone marrow of TallyHo/JngJ T2DM mice

[102]

Elevated in serum during early onset of T1DM in STZ-treated mice

[103]

TNF-α

Elevated in blood and bone marrow of TallyHo/JngJ T2DM mice

[102]

Increased mRNA expression in STZ-treated T1DM mice

[48]

IFN-γ

Elevated in blood and bone marrow of TallyHo/JngJ T2DM mice

[102]

Elevated in serum during early onset of T1DM in STZ-treated mice

[103]

MCSF

Increased mRNA expression in STZ-treated T1DM mice

[48]

MCP-1

Elevated in serum during early onset of T1DM in STZ-treated mice

[103]

  1. RANKL receptor activator of nuclear factor-κB ligand, IL-1 interleukin-1, IL-6 interleukin-6, TNF-α tumor necrosis factor-α, IFN-γ interferon-γ, MCSF macrophage colony-stimulating factor, MCP-1 monocyte chemoattractant protein-1, STZ streptozotocin